Stoke Therapeutics, Inc. (STOK)
34.29
-0.08
(-0.23%)
USD |
NASDAQ |
Feb 20, 16:00
34.28
-0.01
(-0.03%)
After-Hours: 20:00
Stoke Therapeutics SG&A Expense (Quarterly) : 16.03M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biogen, Inc. | 682.50M |
| Insmed, Inc. | 212.48M |
| Pfizer Inc. | 4.162B |
| Mirum Pharmaceuticals, Inc. | 61.91M |
| Moderna, Inc. | 308.00M |